☆ 4.5 Article

Nonsteroidal Anti-inflammatory Drug (NSAID) Tolerance After Biological Therapy in Patients With NSAID-Exacerbated Respiratory Disease: A Randomized Comparative Trial

JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY-IN PRACTICE (2023)

相关参考文献

注意：仅列出部分参考文献，下载原文获取全部文献信息。

Article Allergy

Aspirin desensitization and biologics in aspirin-exacerbated respiratory disease Efficacy, tolerability, and patient experience

Jyotsna Mullur et al.

Summary: The patterns of medication use and treatment experience with biologics and ATAD in patients with aspirin-exacerbated respiratory disease (AERD) need further investigation. The study found that concurrent use of biologics and ATAD was associated with lower efficacy, and among biologics, dupilumab had the highest efficacy.

ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY (2022)

添加到收藏夹

Article Immunology

Dupilumab-associated arthralgia in patients with aspirin-exacerbated respiratory disease: a case series

Lorena Miss Ozuna et al.

ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY (2022)

添加到收藏夹

Article Allergy

Which Is the Best Biologic for Nasal Polyps: Dupilumab, Omalizumab, or Mepolizumab? A Network Meta-Analysis

Qingwu Wu et al.

Summary: Through a systematic review and network meta-analysis, it was found that dupilumab is the best choice for patients with CRSwNP, followed by omalizumab as the second-best option. Mepolizumab, while ranking second in efficacy, had the highest risk of adverse events among the biologics studied.

INTERNATIONAL ARCHIVES OF ALLERGY AND IMMUNOLOGY (2022)

添加到收藏夹

Article Allergy

Appraisal of the Real-World Effectiveness of Biologic Therapies in Aspirin-Exacerbated Respiratory Disease

Hannah Wangberg et al.

Summary: This retrospective pilot study found that anti-IL-4Ra therapy led to significantly higher rates of clinical improvement in patients with AERD compared to anti-IL-5/IL-5Ra and anti-IgE biologic therapies.

JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY-IN PRACTICE (2022)

添加到收藏夹

Article Allergy

Omalizumab-Induced Aspirin Tolerance in Nonsteroidal Anti-Inflammatory Drug-Exacerbated Respiratory Disease Patients Is Independent of Atopic Sensitization

Tamara Quint et al.

Summary: This study investigated the effect of omalizumab treatment on aspirin tolerance in atopic and nonatopic N-ERD patients. The results showed that omalizumab can improve aspirin tolerance in the majority of patients, regardless of atopic sensitization, and has a positive impact on chronic rhinosinusitis with nasal polyps, asthma, and biomarkers.

JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY-IN PRACTICE (2022)

添加到收藏夹

Article Allergy

Efficacy and safety of dupilumab in patients with uncontrolled severe CRSwNP and a clinical diagnosis of NSAID-ERD: Results from two randomized placebo-controlled phase 3 trials

Joaquim Mullol et al.

Summary: In patients with difficult-to-treat CRSwNP, dupilumab significantly improved objective measures and patient-reported symptoms to a greater extent in the presence of comorbid NSAID-ERD than without. Dupilumab was well tolerated in patients with/without NSAID-ERD.

ALLERGY (2022)

添加到收藏夹

Editorial Material Allergy

Comparative efficacy and safety of monoclonal antibodies and aspirin desensitization for chronic rhinosinusitis with nasal polyposis: A systematic review and network meta-analysis

[Anonymous]

JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2022)

添加到收藏夹

Article Allergy

Long-term efficacy and safety of omalizumab for nasal polyposis in an open-label extension study

Philippe Gevaert et al.

Summary: This study confirms the sustained efficacy and safety of omalizumab treatment for chronic rhinosinusitis with nasal polyps for up to one year, which is of significant importance for patients who do not respond to nasal corticosteroids.

JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2022)

添加到收藏夹

Article Allergy

Efficacy and safety of benralizumab in chronic rhinosinusitis with nasal polyps: A randomized, placebo-controlled trial

Claus Bachert et al.

Summary: This study assessed the efficacy and safety of benralizumab in treating CRSwNP. The results showed that benralizumab significantly improved NPS and nasal blockage score, and had significant improvement on difficulty with sense of smell score. Subgroup analyses suggested influences of comorbid asthma, number of NP surgeries, sex, body mass index, and baseline blood eosinophil count on treatment effects.

JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2022)

添加到收藏夹

Article Otorhinolaryngology

Dupilumab as Add-on Therapy for Chronic Rhinosinusitis With Nasal Polyposis in Aspirin Exacerbated Respiratory Disease

S. Shahzad Mustafa et al.

Summary: The study evaluated the efficacy of dupilumab in patients with AERD and found that the drug is highly effective in improving patient outcomes in those with uncontrolled chronic rhinosinusitis with nasal polyposis.

AMERICAN JOURNAL OF RHINOLOGY & ALLERGY (2021)

添加到收藏夹

Letter Allergy

Mepolizumab does not prevent all aspirin-induced reactions in patients with aspirin-exacerbated respiratory disease: A case series

Hannah Martin et al.

JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY-IN PRACTICE (2021)

添加到收藏夹

Article Allergy

The role of aspirin desensitization followed by oral aspirin therapy in managing patients with aspirin-exacerbated respiratory disease: A Work Group Report from the Rhinitis, Rhinosinusitis and Ocular Allergy Committee of the American Academy of Allergy, Asthma & Immunology

Whitney W. Stevens et al.

Summary: AERD is characterized by chronic rhinosinusitis with nasal polyps, asthma, and intolerance to cycloxgenase-1 inhibitors, but most patients benefit from aspirin desensitization and maintenance therapy. This approach improves clinical symptoms and quality of life in AERD patients.

JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2021)

添加到收藏夹

Article Critical Care Medicine

Onset of effect and impact on health-related quality of life, exacerbation rate, lung function, and nasal polyposis symptoms for patients with severe eosinophilic asthma treated with benralizumab (ANDHI): a randomised, controlled, phase 3b trial

Tim W. Harrison et al.

Summary: The study aimed to evaluate the efficacy of benralizumab in severe eosinophilic asthma patients, including onset of effect, impact on health-related quality of life, exacerbation rate, lung function, and nasal polyposis symptoms. Results showed that benralizumab significantly reduced exacerbation risk and improved HRQOL, lung function, and nasal symptoms early in the treatment period compared to placebo.

LANCET RESPIRATORY MEDICINE (2021)

添加到收藏夹

Article Medicine, General & Internal

Management of chronic rhinosinusitis with nasal polyps in Samter triad by low-dose ASA desensitization or dupilumab

Mattis Bertlich et al.

Summary: A study evaluated the efficacy and compliance of ASA and systemic dupilumab therapy in patients with Samter triad, showing that dupilumab is highly effective in treating refractory patients. Additionally, a considerable number of patients discontinued ASA desensitization due to ineffectiveness or side effects.

MEDICINE (2021)

添加到收藏夹

Letter Allergy

Efficacy of dupilumab in patients with aspirin-exacerbated respiratory disease and previous inadequate response to anti-IL-5 or anti-IL-5Rα in a real-world setting

Nicole Bavaro et al.

JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY-IN PRACTICE (2021)

添加到收藏夹

Article Immunology

Dupilumab increases aspirin tolerance in aspirin-exacerbated respiratory disease

S. Shahzad Mustafa et al.

ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY (2021)

添加到收藏夹

Review Multidisciplinary Sciences

Aspirin desensitization in NSAID-exacerbated respiratory disease and its outcomes in the clinical course of asthma: A systematic review of the literature and meta-analysis

Isabel Eraso et al.

Summary: This systematic review included 5 studies with 210 participants with NERD. AD shows a trend towards improving lung function (FEV1) following 6 months of treatment, although no conclusions can be made regarding the use of corticosteroids or the frequency of acute exacerbations. AD appears to reduce both symptom and medication scores.

PLOS ONE (2021)

添加到收藏夹

Article Critical Care Medicine

Mepolizumab for chronic rhinosinusitis with nasal polyps (SYNAPSE): a randomised, double-blind, placebo-controlled, phase 3 trial

Joseph K. Han et al.

Summary: The study aimed to evaluate the efficacy and safety of mepolizumab in adults with recurrent, refractory severe bilateral chronic rhinosinusitis with nasal polyps. Results showed that mepolizumab treatment significantly improved nasal polyp size and nasal obstruction symptoms, with fewer adverse events.

LANCET RESPIRATORY MEDICINE (2021)

添加到收藏夹

Article Critical Care Medicine

Omalizumab for Aspirin Hypersensitivity and Leukotriene Overproduction in Aspirin-exacerbated Respiratory Disease A Randomized Controlled Trial

Hiroaki Hayashi et al.

AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2020)

添加到收藏夹

Article Allergy

Clinical Control of CSU with Antihistamines Allows for Tolerance of NSAID-Exacerbated Cutaneous Disease

Jorge Sanchez et al.

JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY-IN PRACTICE (2020)

添加到收藏夹

Article Allergy

Efficacy and safety of omalizumab in nasal polyposis: 2 randomized phase 3 trials

Philippe Gevaert et al.

JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2020)

添加到收藏夹

Article Allergy

Diagnosis and management of NSAID-Exacerbated Respiratory Disease (N-ERD)a EAACI position paper

Marek L. Kowalski et al.

ALLERGY (2019)

添加到收藏夹

Letter Allergy

Dupilumab improves nasal polyp burden and asthma control in patients with CRSwNP and AERD

Tanya M. Laidlaw et al.

JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY-IN PRACTICE (2019)

添加到收藏夹

Letter Allergy

Mepolizumab utility in successful aspirin desensitization in aspirin-exacerbated respiratory disease in a refractory case

Mahboobeh Mahdavinia et al.

ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY (2019)

添加到收藏夹

Article Allergy

Effect of omalizumab on outcomes in patients with aspirin-exacerbated respiratory disease

Tiffany Jean et al.

ALLERGY AND ASTHMA PROCEEDINGS (2019)

添加到收藏夹

Review Otorhinolaryngology

Effect of Zileuton Treatment on Sinonasal Quality of Life in Patients with Aspirin-Exacerbated Respiratory Disease

Saangyoung E. Lee et al.

AMERICAN JOURNAL OF RHINOLOGY & ALLERGY (2019)

添加到收藏夹

Article Medicine, General & Internal

Efficacy and safety of dupilumab in patients with severe chronic rhinosinusitis with nasal polyps (LIBERTY NP SINUS-24 and LIBERTY NP SINUS-52): results from two multicentre, randomised, double-blind, placebo-controlled, parallel-group phase 3 trials

Claus Bachert et al.

LANCET (2019)

添加到收藏夹

Letter Allergy

Mepolizumab for the treatment of aspirin-exacerbated respiratory disease associated with coronary spasm

David Hagin et al.

JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY-IN PRACTICE (2019)

添加到收藏夹

Review Allergy

NSAID-induced reactions: classification, prevalence, impact, and management strategies

Natalia Blanca-Lopez et al.

JOURNAL OF ASTHMA AND ALLERGY (2019)

添加到收藏夹

Article Allergy

Omalizumab can inhibit respiratory reaction during aspirin desensitization

David M. Lang et al.

ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY (2018)

添加到收藏夹

Review Otorhinolaryngology

Samter's Triad: State of the Art

Sung-Dong Kim et al.

CLINICAL AND EXPERIMENTAL OTORHINOLARYNGOLOGY (2018)

添加到收藏夹

Letter Allergy

Aspirin tolerance in patients with nonsteroidal anti-inflammatory druge exacerbated respiratory disease following treatment with omalizumab

Elsa Phillips-Angles et al.

JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY-IN PRACTICE (2017)

添加到收藏夹

Review Allergy

Cofactors and comorbidities in patients with aspirin/NSAID hypersensitivity

M. Sanchez-Borges et al.

ALLERGOLOGIA ET IMMUNOPATHOLOGIA (2017)

添加到收藏夹

Review Allergy

Aspirin challenge and desensitization: how, when and why

Gabriele Cortellini et al.

CURRENT OPINION IN ALLERGY AND CLINICAL IMMUNOLOGY (2017)

添加到收藏夹

Article Allergy

Chronic Rhinosinusitis and Aspirin-Exacerbated Respiratory Disease

Neha M. Dunn et al.

IMMUNOLOGY AND ALLERGY CLINICS OF NORTH AMERICA (2016)

添加到收藏夹

Review Allergy

Aspirin or Nonsteroidal Anti-inflammatory Drug-Exacerbated Chronic Rhinosinusitis

Dennis K. Ledford et al.

JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY-IN PRACTICE (2016)

添加到收藏夹

Review Pharmacology & Pharmacy

Hypersensitivity Reactions to Non-Steroidal Anti-Inflammatory Drugs

Inmaculada Dona et al.

CURRENT PHARMACEUTICAL DESIGN (2016)

添加到收藏夹

Article Allergy

NSAID-exacerbated respiratory disease: a meta-analysis evaluating prevalence, mean provocative dose of aspirin and increased asthma morbidity

D. R. Morales et al.

ALLERGY (2015)

添加到收藏夹

Article Allergy

Safety risks for patients with aspirin-exacerbated respiratory disease after acute exposure to selective nonsteroidal anti-inflammatory drugs and COX-2 inhibitors: Meta-analysis of controlled clinical trials

Daniel R. Morales et al.

JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2014)

添加到收藏夹

Review Allergy

Hypersensitivity to nonsteroidal anti-inflammatory drugs (NSAIDs) - classification, diagnosis and management: review of the EAACI/ENDA and GA2LEN/HANNA

M. L. Kowalski et al.

ALLERGY (2011)

添加到收藏夹

© Peeref 2019-2024. All rights reserved.